Probiotec

Probiotec is a leading Australian contract development and manufacturing organization (CDMO) that provides end-to-end solutions for the pharmaceutical and consumer health industries. The company specializes in the formulation, manufacturing, and packaging of a wide range of prescription medicines, over-the-counter (OTC) products, and complementary medicines. With multiple TGA-licensed facilities, Probiotec offers diverse dosage formats including tablets, capsules, liquids, creams, and gels. In June 2024, the company was acquired by the Indonesian pharmaceutical firm Pyridam Farma, significantly expanding its reach across the Asia-Pacific region. Probiotec continues to serve a global client base, ranging from major multinational pharmaceutical companies to boutique local brands.